Microarray expression profiles analysis revealed lncRNA OXCT1-AS1 promoted bladder cancer cell aggressiveness via miR-455-5p/JAK1 signaling

A systematic review and meta-analysis of lymphovascular invasion in patients treated with radical cystectomy for bladder cancer

(2018) Andrea Mari et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

High expression of long noncoding RNA NORAD indicates a poor prognosis and promotes clinical progression and metastasis in bladder cancer

(2018) Qiaqia Li et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Tight Junction Protein 1 Dysfunction Contributes to Cell Motility in Bladder Cancer

(2018) KUO-WANG TSAI et al.   ANTICANCER RESEARCH

LncRNA PVT1 regulates VEGFC through inhibiting miR-128 in bladder cancer cells

(2018) Cui Yu et al.   JOURNAL OF CELLULAR PHYSIOLOGY

A Phase Ib/II Study of the JAK1 Inhibitor, Itacitinib, plusnab‐Paclitaxel and Gemcitabine in Advanced Solid Tumors

(2018) Gregory L. Beatty et al.   ONCOLOGIST

Role of long non-coding RNAs in glucose metabolism in cancer

(2017) Chunmei Fan et al.   Molecular Cancer

MicroRNA-455 inhibits cell proliferation and invasion of epithelial ovarian cancer by directly targeting Notch1

(2017) Lixia Xu et al.   Molecular Medicine Reports

Long Noncoding RNAs as Novel Biomarkers Have a Promising Future in Cancer Diagnostics

(2016) Ting Shi et al.   DISEASE MARKERS

MiR-455-5p acts as a novel tumor suppressor in gastric cancer by down-regulating RAB18

(2016) Jichao Liu et al.   GENE

Potential of long non-coding RNAs in cancer patients: From biomarkers to therapeutic targets

(2016) Subash Chandra Gupta et al.   INTERNATIONAL JOURNAL OF CANCER

Bladder cancer

(2016) Ashish M Kamat et al.   LANCET

Long Non-coding RNAs in Urologic Malignancies: Functional Roles and Clinical Translation

(2016) Jiajia Chen et al.   Journal of Cancer

Reduced adenosine-to-inosine miR-455-5p editing promotes melanoma growth and metastasis

(2015) Einav Shoshan et al.   NATURE CELL BIOLOGY

Pharmacologic Suppression of JAK1/2 by JAK1/2 Inhibitor AZD1480 Potently Inhibits IL-6-Induced Experimental Prostate Cancer Metastases Formation

(2014) L. Gu et al.   MOLECULAR CANCER THERAPEUTICS

Targeting JAK1/STAT3 Signaling Suppresses Tumor Progression and Metastasis in a Peritoneal Model of Human Ovarian Cancer

(2014) W. Wen et al.   MOLECULAR CANCER THERAPEUTICS

c-Src Binds to the Cancer Drug Ruxolitinib with an Active Conformation

(2014) Yankun Duan et al.   PLoS One

Volatile evolution of long noncoding RNA repertoires: mechanisms and biological implications

(2014) Aurélie Kapusta et al.   TRENDS IN GENETICS

Conditional Survival After Radical Cystectomy for Bladder Cancer: Evidence for a Patient Changing Risk Profile over Time

(2013) Guillaume Ploussard et al.   EUROPEAN UROLOGY

Long Noncoding RNA in Prostate, Bladder, and Kidney Cancer

(2013) Elena S. Martens-Uzunova et al.   EUROPEAN UROLOGY

Long non-coding RNAs: new players in cell differentiation and development

(2013) Alessandro Fatica et al.   NATURE REVIEWS GENETICS

Inhibiting autophagy potentiates the anticancer activity of IFN1@/IFNα in chronic myeloid leukemia cells

(2012) Shan Zhu et al.   Autophagy

A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language?

(2011) Leonardo Salmena et al.   CELL

Preclinical characterization of the selective JAK1/2 inhibitor INCB018424: therapeutic implications for the treatment of myeloproliferative neoplasms

(2010) A. Quintas-Cardama et al.   BLOOD